Next Article in Journal
The Effects of Osteopathic Manipulative Treatment on Brain Activity: A Scoping Review of MRI and EEG Studies
Next Article in Special Issue
Impact of Nonsurgical Periodontal Treatment of Periodontitis Stages 2 and 3 on Oral Health-Related Quality of Life
Previous Article in Journal
Acceptability of Medical Male Circumcision as an HIV Prevention Intervention among Male Learners in a South African High School
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Oral Health-Related Quality of Life in an Institutionalized Population with HIV+/AIDS in the Northern Region of Mexico

by
Luis Alberto Gaitán-Cepeda
1,*,
Nydia Alejandra Castillo-Martínez
2,
María del Carmen Villanueva-Vilchis
3,
José Román Chávez-Méndez
2,
Ángel Gastón Peralta-Alegría
2,
Jaime Paúl Ferré-Soto
2 and
Diana Ivette Rivera-Reza
1
1
Department of Oral and Maxillofacial Medicine and Pathology, Research and Graduate Division, Dental School, National Autonomous University of Mexico, Mexico City 04510, Mexico
2
Microbiology Laboratory, Facultad de Ciencias de la Salud, Universidad Autónoma de Baja California, Tijuana 21100, Mexico
3
Department of Oral Public Health, School of Superior Studies, National Autonomous University of Mexico, León 37684, Mexico
*
Author to whom correspondence should be addressed.
Healthcare 2024, 12(13), 1352; https://doi.org/10.3390/healthcare12131352
Submission received: 14 May 2024 / Revised: 14 June 2024 / Accepted: 3 July 2024 / Published: 6 July 2024

Abstract

:
Approximately 39 million people worldwide live with human immunodeficiency virus (HIV), and antiretroviral therapy (ART) has improved life expectancy for these individuals, with quality of life (QoL) being a crucial aspect. However, there is limited information on oral health-related quality of life (OHRQoL) for institutionalized patients with HIV. This study used a cross-sectional design and included 43 residents of a non-governmental institution who had a confirmed HIV diagnosis and a history of intravenous drug use. The Spanish version of the Oral Health Index Profile-14 (OHIPsp) was used to assess the OHRQoL, with the 50th percentile serving as the cutoff for good or poor quality of life. All 43 patients had one or more oral lesions, with 44.1% having AIDS-related oral lesions (AROLs). Over half of the participants (48.8%) reported a poor OHRQoL, and females experienced worse quality of life in all dimensions compared to males. Subjects with AROLs were three times more likely to have poor OHRQoL than those without AROLs (p = 0.03; OR = 3.1 IC 1.04–9.6). These results highlight the need for a comprehensive treatment plan for patients with HIV that includes oral health, particularly for women living in precarious conditions or who are institutionalized. Improving oral health can significantly enhance quality of life.

1. Introduction

Human immunodeficiency virus (HIV) is one of the most significant pandemics that affects humans worldwide. Approximately 85.6 million people (64.8 million–113.0 million) have been infected with HIV since the start of the pandemic, and 40.4 million (32.9 million–51.3 million) people have died from AIDS-related illnesses since the start of the epidemic [1]. Despite efforts to control the pandemic, 39 million (33.1 million–45.7 million) people live with HIV; therefore, the eradication of the virus seems to be a distant goal [1]. The introduction of highly active antiretroviral therapy (HAART) in the mid-1990s led to a significant reduction in the morbidity and mortality associated with HIV infection [2] and an increase in life expectancy. HIV infection has been reclassified as a chronic disease. The objective of anti-HIV treatment now not only includes the control and prevention of HIV viremia and opportunistic infections, but also actions aimed at improving the quality of life (QoL) and overall well-being of HIV+ individuals. The increase in life expectancy of patients with HIV is accompanied by the need to improve their quality of life.
Health-related quality of life (HRQoL) is an individual’s subjective perception of their ability to perform essential activities and is influenced by their current health status [3]. This assessment reflects the impact of a disease and its treatment on an individual’s perception of well-being [4]. Oral health-related quality of life (OHRQoL) refers to the impact of oral conditions, lesions, or diseases on a subject’s functional, social, psychological, and financial aspects [5]. Therefore, oral health and QoL are essential for overall health and well-being [4]. Early clinical findings indicate that oral infections, notably oral candidiasis and hairy leukoplakia, are closely related to HIV infection [6]. Oral candidiasis and hairy leukoplakia are believed to have significant diagnostic and prognostic relevance [7,8,9], and oral candidiasis serves as an important clinical marker of immune system dysfunction in patients receiving antiretroviral therapy (ART) [9].
Some articles in the scientific literature (e.g., [10,11,12]) reported the impact of oral health on the quality of life of people living with HIV/AIDS (PLWHA). While HIV subjects have been reported to have poor OHRQoL, associated with the presence of oral lesions [10,11], other studies have found risk factors similar to the non-HIV population [12]. The data on the effects of oral health on QoL are scarce, and information remains inconclusive [13,14,15].
An important factor contributing to this apparent contradiction is the diversity of the PLWHA subpopulations [16]. Subpopulations of PLWHA exhibit diverse characteristics influenced by social, demographic, and economic situations, including treatment accessibility and adherence to antiretroviral therapy (ART). The northern region of Mexico, particularly Tijuana Valley, has a significant number of migrants, resulting in a significant floating population who may not have access to healthcare services. The objective of the present study was to investigate the impact of oral lesions on the OHRQoL of institutionalized adult patients with HIV undergoing ART in Northern Mexico. These data highlight their perceived need and will enable the establishment of preventive measures and interventions to improve the quality of life of subjects who are HIV positive.

2. Materials and Methods

Study Design and Subject. This transversal study encompassed residents of a non-governmental institution (Las Memorias A. C, Tijuana, Baja California, Mexico), focusing on housing subjects, with a confirmed diagnosis of HIV infection and a history of intravenous drug use. All participants volunteered and received comprehensive explanations of the study objectives, scope, and procedures. Before the study, the participants signed an informed consent form that guaranteed the confidentiality and anonymity of the data and the option to withdraw from the study at any time. This study was conducted in November 2018. The research protocol was authorized by the Research and Bioethics Committee of Escuela de Ciencias de la Salud, Universidad Autónoma de Baja California (registration number 009/2018; September 2018).
Inclusion criteria required participants to have a confirmed diagnosis of HIV infection and a history of intravenous drug use to be able to complete the interview.
Exclusion criteria included those who did not provide complete information or had any impediments to completing the interview. Patients who were psychologically compromised, had neurological deficits, or refused to provide informed consent were excluded from the study.
Oral examination. The oral examination was conducted by an expert in oral medicine (LAGC) who utilized all necessary protective measures, including a dental chair, dental mirrors, and artificial light. The examiner collected information on the presence of dental, AIDS-related oral lesions not related to HIV+/AIDS using clinical parameters. Caries was visually identified based on the World Health Organization criteria [17], where the presence of any cavitation associated with the presence of biofilm is registered as caries. On the other hand, as this was a field study in immunocompromised patients, the evaluation of the presence of gingivitis was purely visual, taking into account the general presence of inflammation, bleeding, and/or redness of the gingival tissues.
Oral health index profile and oral health-related quality of life. After oral examination, all participants were interviewed in person using the Oral Health Impact Profile (OHIP-14sp). OHIP-14 is a widely validated instrument for assessing the impact of oral health on an individual’s quality of life [18,19,20]. The OHIP-14 version has been validated in Spanish. It is considered a comprehensive and reliable psychometric tool for assessing seven dimensions of OHRQoL: functional limitations, pain, psychological discomfort, physical disability, psychological disability, social disability, and incapacity [21]. Since its validation in 2009, the OHIP-14 has not been significantly modified and remains a valid and reliable measure of oral health-related quality of life. The OHIPsp uses a Likert-type scale ranging from 0 (never) to 4 (almost always) to evaluate the frequency of functional problems experienced in daily life owing to oral lesions. The responses were then coded and scored using the additive method, with a minimum possible score of 0 and a maximum score of 56. A higher score indicates a lower quality of life. The 50th percentile (median) was used as the cutoff point for good or bad quality of life in accordance with previous publications of our research group [22,23].
Statistical analysis. The statistical analysis included calculating the means and standard deviations for quantitative variables such as age and quality of life and percentages for qualitative variables. Student’s t-test (p < 0.05) was used to verify the difference in the mean OHIP-14 by sex. To confirm the association between good and poor quality of life with respect to sex and with respect to oral lesions, the chi-square test with a 95% confidence interval was used. Finally, the odds ratio value was obtained to determine the risk of having a poor quality of life according to the type of lesion present.

3. Results

Clinical and demographical characteristics. Forty-three institutionalized patients with HIV/AIDS (32 male [74%] and 11 women [25.6%]) were included in this study. The mean age was 44.7 years (standard deviation [SD] ± 9.55). The following oral conditions and lesions were diagnosed: regarding dental conditions, dental caries, residual dental roots, tooth loss, gingivitis, and periapical abscess were diagnosed; regarding AIDS-related oral lesions (AROLs), hairy leukoplakia, pseudomembranous candidiasis, erythematous candidiasis, and angular cheilitis were diagnosed; and regarding conditions not related to HIV+/AIDS, fissured tongue, saburral tongue, xerostomia, and melanotic macula were diagnosed.
All 43 patients exhibited one or more oral lesions, and we did not observe any lesion-free subjects. A total of 43 (100%) subjects presented with dental alterations, 21 (49.8%) had residual roots, and 9 presented with gingivitis. As for dental lesions, tooth loss remained constant due to a prevalence of 100%, followed by caries with 86%; 47.6% of the subjects presented with residual dental roots, gingivitis was observed in 19% of subjects, and periapical abscess was observed in 9.5% of subjects. Regarding oral mucosal lesions not related to HIV/AIDS, two subjects presented with a saburral tongue, and two presented with a fissured tongue. AROLs were diagnosed as erythematous or pseudomembranous candidiasis in seven cases, hairy leukoplakia in four cases, and angular cheilitis in eight cases. Antiretroviral treatment-related conditions, namely xerostomia and melanocytic macules, were identified in this population with prevalence rates of 13.95% and 6.9%, respectively. The total number of oral lesions was 143. The number of lesions was greater than that in the subjects because all patients concomitantly presented with two or more lesions.
Oral health index profile results. The mean OHIP-14 value was 28.4 (SD ± 12.35), ranging from 4 to 51. Females had a mean OHIP-14 value of 31.6 (SD ± 14.37), ranging from 11 to 51, while males had a mean value of 27.4 (SD ± 11.67), ranging from 4 to 47. The dimension with the highest OHIP-14 score was psychological discomfort (6.1) (SD ± 2.17), followed by functional limitation (5.23) (SD ± 2.39). Regarding gender, in the females, the dimensions with the greatest values and consequently the most significant impact on quality of life were psychological discomfort (6.2) (SD ± 2.24), followed by functional limitation (5.3) (SD ± 2.54) and pain (5.09; SD ± 2.21). In males, the dimensions with the highest scores were psychological discomfort (6.09; SD ± 2.19) and functional limitation (5.1; ± 2.38). The comparison of means found that women had a worse OHRQoL in the dimension of disability than males, with the difference being 4.4 vs. 2.7 (p = 0.048). Although the rest of the dimensions did not show statistical significance (Table 1), women reported worse QoL in all dimensions.
Oral health-related quality of life. The participants were categorized into good and poor quality of life groups, with the 50th percentile (median) being the cutoff point. Thus, values >50 were classified as a poor quality of life, whereas values <50 were considered good. Of the total sample (n = 43), 21 patients (48.8%) were classified as having a poor QoL related to oral health. The chi-square test was used to identify whether there was an association based on sex; however, no dimension showed statistical significance, as shown in Table 2.
When relating poor QoL (n = 21) with AROLs, we found that six (28.6%) patients had angular cheilitis, five (23.8%) had candidiasis, and three (14.3%) had hairy leukoplakia. The association between AROLs and poor quality of life was statistically significant (p = 0.03; OR 3.1IC 1.04–9.6) (Table 3). Thus, subjects with AROLs were three times more likely to have a poor quality of life than subjects with HIV+/AIDS who did not have AIDS-related lesions.

4. Discussion

The purpose of this study was to determine the impact of oral health on the quality of life of institutionalized patients with HIV/AIDS under ART in the northern region of Mexico. Our results show that women had higher scores for all dimensions of the OHIP-14sp. The dimensions with the highest scores were psychological discomfort, functional limitation, and pain. This suggests a poorer QoL for institutionalized women with HIV/AIDS than for men with HIV/AIDS. A poor QoL is closely associated with AROLs. Subjects with HIV/AIDS who present poor oral health and are explicitly suffering from AROLs have a significantly worse OHRQoL than the HIV-seronegative population [10,13,14,15,24] and a worse QoL than that of women with HIV [25,26,27]. In our sample, the most affected dimension was psychological discomfort, which agrees with previous reports that place the worst values on the psychological dimensions [13,27,28]. The data mentioned above are relevant because psychological discomfort is a trigger or amplifier of anxiety and depression, which are common in subjects with HIV [13]. Our research group established an association between psychological discomfort and anxiety or depression in a previous study of patients with oral lichen planus (OLP) [23].
It is important to point out that all participants in the present study presented with dental problems. Dental caries was significantly associated with a poorer OHRQoL [26,29], and high decayed teeth index and dental loss are independently associated with OHIP scores [11]. Oral health programs are needed to improve the OHRQoL of PLWHA. Dental issues with the most significant impact are difficulty chewing food, pain when chewing, toothaches, and loose teeth. Some putative explanations for the high prevalence of dental problems in PLWAH have been proposed. On the one hand, this could result from a lack of interest or underestimation of its importance by patients. The study population had health priorities other than dental care. On the other hand, social and demographic factors such as employment and social and public health support have been associated with the OHRQoL of PLWHA [10,11,15,25,27,30]. The population in the present report had no jobs or governmental or social support, and the shelter did not have permanent dental services; therefore, they did not have access to dental treatment, including private dental treatment, because of a lack of income. Accordingly, active dental caries or sequelae of dental caries were present in 100% of the HIV subjects involved.
To our knowledge, the present study is the first to examine the OHRQoL in institutionalized patients with HIV. There are few studies on the quality of life of (no-institutionalized) subjects with HIV in relation to oral health. Because different tools have been used to determine the impact of oral health on the quality of life of PLWHA, comparisons are complicated. Therefore, we reviewed the scientific literature and identified and isolated 11 papers that used OHIP 49/14 as a research tool (Table 4). Four used OHIP-49 [10,11,25,27], and seven studies used OHIP-14 [13,14,15,16,26,30,31]. However, even though OHIP-14/49 within a group of culturally homogenous individuals has high internal reliability, consistency, and validity [10], there are two methods to establish a poor or good quality of life: by using the percentage of responses to each question and by using the 50th quartile. Both methods are correct and offer interesting data but also prevent comparisons, deeper analysis, and meta-analysis. In addition, several articles only reported the total OHIP results without including the results by dimension. Homogenizing strategies to establish a cutoff point for good or bad quality of life would be desirable. As shown in the table, there is only one report on the institutionalized prison population. The remaining studies were conducted on outpatients. Therefore, the present study is the first to establish the impact of oral health on the quality of life of institutionalized PLWHA. Four articles that used the OHIP-49 as a research tool were identified [10,11,25,27]. The total value ranged from 14.4 in South African subjects without AROLs [10] to 123.3 reported in Portuguese subjects with HIV [11]. In the case of the results obtained using the OHIP-14 [13,14,15,16,26,30,31], the total value variation was also wide, ranging from 5.8 reported in Portugal [26] to 28.4 reported in the United States [15]. We obtained a total OHIP-14 value of 28.46, which places the institutionalized population of Northern Mexico at a higher score, meaning it has the lowest OHQoL compared to the published data. A study in Florida showed that subjects who were institutionalized or in prison had the highest score compared to subjects who were in their own homes, temporary housing, another person’s home, a drug treatment center, or even on the street [27].
This is the first study on the OHRQoL among institutionalized PLWHA on the northern region of Mexico. The majority of patients, before their inclusion in the institution, were homeless without economic resources or family support. Subjects in this situation are considered to have a high risk of HIV infection because the use of intravenous-recreational drugs is widespread in this population [32,33]. The “Las Memorias” shelter is a non-profit organization that houses individuals with a history of intravenous drug use and who are also HIV+; most of them have these experiences due to migration. The most frequent reason for all included subjects to be in the Tijuana Valley was migration to the USA. Tijuana, Mexico is the largest city on the Mexican–USA border in the state of Baja California, and it is situated on major migration. Migrants live in an important risk environment, including social networks; injection locations; population mobility; unavailable health services, including dental ones; inequities to ethnicity; and social stigma and discrimination [33]. Most subjects included in the present study were homeless at indeterminate times. Homelessness has been associated with a greater risk of HIV infection [34].
The present study has several limitations. We used a cross-sectional design with inherent methodological limitations as it is challenging to establish the correct temporal sequence of exposure and effect. We could not obtain the patients’ important social, demographical, and clinical data. Most patients did not know when or how they acquired the infection; we were unable to collect the infection times under HAART because although the included patients had been in the shelter for at least six months, they often did not remember whether they had previously undergone antiretroviral treatment, and if so, what kind of ART. Moreover, some patients needed an identity document. Regarding clinical aspects, there was a lack of objective measurements regarding dental caries and gingivitis/periodontitis; thus, we cannot assess the DMFT index or periodontal status. Although it is ideal to use an index, caries prevalence has also been used to indicate dental health status (Indu). The DMFT index is used to measure oral health. However, the DMFT index fails to take into account multidimensional measures of diseases (INDU) that are very complex in PLWHA. On the other hand, we would like to emphasize the value of having included the prevalence of both caries and gingivitis, which provides information on the oral health of the population, establishing that this prevalence was high and that the effect of this variable is homogeneous in the population studied, establishing the effect of the lesions themselves as a difference.
The lack of a control group was a weakness of this study. Future studies on this population should take into account the particularity of the study group, which includes institutionalized patients who are HIV positive with a history of intravenous drug use and migrants, to find an adequate control group. We do not doubt that including a control group would have made the conclusions more solid and robust.
Finally, the present study addresses the quality of life of PLWHA who are institutionalized, a particular subpopulation, so our results cannot be extrapolated to all PLWHA.

5. Conclusions

Subjects with HIV/AIDS who are institutionalized in the northern region of Mexico, specifically women, have a poor OHRQoL. Our results highlight the need to establish a comprehensive treatment for PLWA that includes oral health, especially in subjects living with precarious conditions or who are institutionalized; improvements in oral health consequently improve quality of life. A poor quality of life is related to dental lesions and AROLs. Due to poor oral health and high treatment needs in the study setting, this population represents a vital priority group for the prompt delivery of dental care. More attention should be paid to common oral diseases, such as caries and periodontal diseases, where it is vital to establish routine dental check-ups for PLWHA. To further validate our findings, we propose a follow-up study (or cohort) to determine whether AROL treatment and dental rehabilitation improve QoL.
Because human migration is not expected to decrease in the short or medium term, it is essential to know this population’s health conditions and dental health, which can profoundly affect their already precarious quality of life.

Author Contributions

Conceptualization, L.A.G.-C., N.A.C.-M. and J.R.C.-M.; methodology, L.A.G.-C. and M.d.C.V.-V.; validation, J.R.C.-M. and M.d.C.V.-V.; formal analysis, M.d.C.V.-V., D.I.R.-R.; investigation, L.A.G.-C. and N.A.C.-M.; resources, N.A.C.-M. and J.R.C.-M.; data curation, D.I.R.-R., Á.G.P.-A. and J.P.F.-S.; writing—original draft preparation, L.A.G.-C.; writing—review and editing, N.A.C.-M. and J.R.C.-M.; project administration, N.A.C.-M. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

This study was conducted in accordance with the Declaration of Helsinki and approved by the Institutional Review Board and Ethics Committee of Escuela de Ciencias de la Salud, Universidad Autónoma de Baja California (registration number 009/2018, 19 December 2018).

Informed Consent Statement

Informed consent was obtained from all subjects involved in this study.

Data Availability Statement

Data are contained within the article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. UNAIDS. Global HIV & AIDS Statistics-Fact Sheet. Available online: https://www.unaids.org/en/resources/fact-sheet (accessed on 30 March 2024).
  2. Montaner, J.S.G.; Lima, V.D.; Harrigan, P.R.; Lourenço, L.; Yip, B.; Nosyk, B.; Wood, E.; Kerr, T.; Shannon, K.; Moore, D.; et al. Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: The “HIV Treatment as Prevention” experience in a Canadian setting. PLoS ONE 2014, 9, e87872. [Google Scholar] [CrossRef] [PubMed]
  3. Schwartzmann, L. Quality of life related to health: Conceptual aspects. Sci. Nurs. 2003, 2, 9–21. [Google Scholar]
  4. Baiju, R.M.; Peter, E.; Varghese, N.O.; Sivaram, R. Oral health and quality of life: Current concepts. J. Clin. Diagn. Res. 2017, 11, ZE21–ZE26. [Google Scholar] [CrossRef] [PubMed]
  5. Sheiham, A. Oral health, general health and quality of life. Bull. World. Health Organ. 2005, 83, 644. [Google Scholar] [PubMed]
  6. Ceballos-Salobreña, A.; Gaitán-Cepeda, L.A.; Ceballos-Garcia, L.; Lezama-Del Valle, D. Oral lesions in HIV/AIDS patients undergoing highly active antiretroviral treatment including protease inhibitors: A new face of oral AIDS? AIDS Patient Care STDS 2000, 14, 627–635. [Google Scholar] [CrossRef]
  7. Ramírez-Amador, V.; Ponce-De-León, S.; Sierra-Madero, J.; Soto-Ramírez, L.; Esquivel-Pedraza, L.; Anaya-Saavedra, G. Synchronous kinetics of CD4+ lymphocytes and viral load before the onset of oral candidosis and hairy leukoplakia in a cohort of Mexican HIV-infected patients. AIDS Res. Hum. Retroviruses 2005, 21, 981–990. [Google Scholar] [CrossRef] [PubMed]
  8. Fernández-Feijoo, J.; Diz-Dios, P.; Otero-Cepeda, X.L.; Limeres-Posse, J.; de la Fuente-Aguado, J.; Ocampo-Hermida, A. Predictive value of oral candidiasis as a marker of progression to AIDS. Med. Oral Patol. Oral Cir. Bucal 2005, 10, 36–40. [Google Scholar] [PubMed]
  9. Gaitán-Cepeda, L.A.; Martínez-González, M.; Ceballos-Salobreña, A. Oral candidosis as a clinical marker of immune failure in patients with HIV/AIDS on HAART. AIDS Patient Care STDS 2005, 19, 70–77. [Google Scholar] [CrossRef] [PubMed]
  10. Yengopal, V.; Naidoo, S. Do oral lesions associated with HIV affect quality of life? Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontology 2008, 106, 66–73. [Google Scholar] [CrossRef]
  11. Rocha Trindade, R.T.V.M.; Marques, J.R.O.F.; Veiga, M.A.G.D.; Marques, D.N.D.S.; Mata, A.D.S.P.D. HIV-1 impact on oral health-related quality of life: A cross-sectional study. AIDS Care 2021, 33, 1321–1328. [Google Scholar] [CrossRef]
  12. Jeganathan, S.; Batterham, M.; Begley, K.; Purnomo, J.; Houtzager, L. Predictors of oral health quality of life in HIV-1 infected patients attending routine care in Australia. J. Public Health Dent. 2011, 71, 248–251. [Google Scholar] [CrossRef] [PubMed]
  13. Mohamed, N.; Mohamed, N.; Saddki, N.; Yusoff, A.; Jelani, A.M. Association among oral symptoms, oral health-related quality of life, and health-related quality of life in a sample of adults living with HIV/AIDS in Malaysia. BMC Oral Health 2017, 17, 119. [Google Scholar] [CrossRef] [PubMed]
  14. de Quadros Coelho, M.; Cordeiro, J.M.; Vargas, A.M.; de Barros Lima Martins, A.M.; de Almeida Santa Rosa, T.T.; Senna, M.I.; Ferreira, R.C. Functional and psychosocial impact of oral disorders and quality of life of people living with HIV/AIDS. Qual. Life. Res. 2015, 24, 503–511. [Google Scholar] [CrossRef] [PubMed]
  15. Mulligan, R.; Seirawan, H.; Alves, M.E.; Navazesh, M.; Phelan, J.A.; Greenspan, D.; Greenspan, J.S.; Mack, W.J. Oral health-related quality of life among HIV-infected and at-risk women. Community Dent. Oral Eidemiol. 2008, 36, 549–557. [Google Scholar] [CrossRef] [PubMed]
  16. Busato, I.M.; Thomaz, M.; Toda, A.I.; Alanis, D.G.; França, B.H.; de Lima, A.A.; Azevedo-Alanis, L.R. Prevalence and impact of xerostomia on the quality of life of people living with HIV/AIDS from Brazil. Spec. Care Dent. 2013, 33, 128–132. [Google Scholar] [CrossRef] [PubMed]
  17. World Health Organization. Oral Health Surveys. Basic Methods, 5th ed.; World Health Organization: Monts, France, 2013. [Google Scholar]
  18. de Souza, R.F.; Terada, A.S.; Vecchia, M.P.; Regis, R.R.; Zanini, A.P.; Compagnoni, M.A. Validation of the Brazilian versions of two inventories for measuring oral health-related quality of life of edentulous subjects. Gerodontology 2012, 29, e88–e95. [Google Scholar] [CrossRef]
  19. Montero-Martin, J.; Bravo-Pérez, M.; Albaladejo-Martinez, A.; Hernández-Martin, L.A.; Rosel-Gallardo, E.M. Validation the Oral Health Impact Profile (OHIP-14sp) for adults in Spain. Med. Oral Patol. Oral Cir. Bucal 2009, 14, E44–E50. [Google Scholar]
  20. Slusanschi, O.; Moraru, R.; Garneata, L.; Mircescu, G.; Cuculescu, M.; Preoteasa, E. Validation of a Romanian version of the short form of the oral health impact profile (OHIP-14) for use in an urban adult population. Oral Health Prev. Dent. 2013, 11, 235–242. [Google Scholar] [CrossRef]
  21. Castrejon-Perez, R.C.; Borges-Yanez, S.A.; Irigoyen-Camacho, M.E. Validación de un instrumento para medir el efecto de la salud bucal en la calidad de vida de adultos mayores mexicanos. Rev. Panam. Salud Publica 2010, 27, 321–329. [Google Scholar] [CrossRef]
  22. Villanueva-Vilchis, M.D.; López-Ríos, P.; Maya-García, I.; Gaitán-Cepeda, L.A. Impact of oral mucosa lesions on the quality of life related to oral health. An etiopathogenic study. Med. Oral Patol. Oral Cir. Bucal. 2016, 21, e178–e184. [Google Scholar] [CrossRef]
  23. Gaitán-Cepeda, L.A.; Rivera-Reza, D.I.; Villanueva-Vilchis, M.D.C. Neuroticism and psychological stress in patients suffering oral lichen planus: Research evidence of psycho-stomatology? Healthcare 2023, 11, 1738. [Google Scholar] [CrossRef] [PubMed]
  24. Sufiawati, I.; Amalia, T.; Dewi, T.S.; Wisaksana, R. The association between oral mucosal lesions and oral health-related quality of life using the validated Indonesian version of ohip-14 among people living with HIV/AIDS. HIV/AIDS-Res. Palliat. Care 2024, 16, 9–16. [Google Scholar] [CrossRef] [PubMed]
  25. Sánchez, G.A.; D’Eramo, L.R.; Lecumberri, R.; Squassi, A.F. Impact of oral health care needs on health-related quality of life in adult HIV+ patients. Acta Odontológica Latinoam. 2011, 24, 92–97. [Google Scholar]
  26. Santo, A.E.; Tagliaferro, E.P.; Ambrosano, G.M.; Meneghim, M.C.; Pereira, A.C. Dental status of Portuguese HIV+ patients and related variables: A multivariate analysis. Oral Dis. 2010, 16, 176–184. [Google Scholar] [CrossRef] [PubMed]
  27. Tomar, S.L.; Pereyra, M.; Metsch, L.R. Oral health-related quality of life among low-income adults living with HIV. J. Public Health Dent. 2011, 71, 241–247. [Google Scholar] [CrossRef] [PubMed]
  28. Shaghaghian, S.; Saranjam, E.; Homayooni, M. Oral health-related quality of life in patients infected with HIV, Iran: A cross-sectional study. BMC Oral Health 2021, 21, 308. [Google Scholar] [CrossRef]
  29. Murererehe, J.; Malele-Kolisa, Y.; Niragire, F.; Yengopal, V. Oral health-related quality of life among people living with HIV and HIV-negative adults in Kigali, Rwanda: A comparative cross-sectional study. BMC Oral Health 2024, 24, 128. [Google Scholar] [CrossRef] [PubMed]
  30. Umeizudike, K.A.; Osagbemiro, B.B.; Daramola, O.O.; Adeyemo, T.A. Oral health related quality of life among HIV positive patients attending two HIV outpatient clinics in Nigeria—A cross sectional study. Afr. Health Sci. 2021, 21, 566–575. [Google Scholar] [CrossRef] [PubMed]
  31. Umniyati, H.; Noviani, R.P.; Masriadi. Determine relationship between xerostomia and quality of life of HIV person’s living in prison. J. Int. Soc. Prev. Community Dent. 2022, 12, 360–364. [Google Scholar]
  32. Strathdee, S.A.; Lozada, R.; Pollini, R.A.; Brouwer, K.C.; Mantsios, A.; Abramovitz, D.A.; Rhodes, T.; Latkin, C.A.; Loza, O.; Alvelais, J.; et al. Individual, social, and environmental influences associated with HIV infection among injection drug users in Tijuana, Mexico. J. Acquir. Immune Defic. Syndr. 2008, 47, 369–376. [Google Scholar] [CrossRef]
  33. Degenhardt, L.; Webb, P.; Colledge-Frisby, S.; Ireland, J.; Wheeler, A.; Ottaviano, S.; Willing, A.; Kairouz, A.; Cunningham, E.B.; Hajarizadeh, B.; et al. Epidemiology of injecting drug use, prevalence of injecting-related harm, and exposure to behavioural and environmental risks among people who inject drugs: A systematic review. Lancet Glob. Health 2023, 11, e659–e672. [Google Scholar] [CrossRef] [PubMed]
  34. Arum, C.; Fraser, H.; Artenie, A.A.; Bivegete, S.; Trickey, A.; Alary, M.; Astemborski, J.; Iversen, J.; Lim, A.G.; MacGregor, L.; et al. Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: A systematic review and meta-analysis. Lancet Public Health 2021, 6, e309–e323. [Google Scholar] [CrossRef] [PubMed]
Table 1. Values of dimensions of OHIP-14 regarding gender.
Table 1. Values of dimensions of OHIP-14 regarding gender.
DIMENSIONS TOTAL
(n = 43)
FEMALE
(n = 11)
MALE
(n = 32)
p *
Functional limitations5.23
(±2.39)
5.36
(±2.54)
5.19
(±2.38)
0.83
Pain 4.58
(±2.18)
5.09
(±2.21)
4.41
(±2.18)
0.37
Psychological discomfort6.14
(±2.18)
6.27
(±2.24)
6.09
(± 2.19)
0.81
Physical disability3.28
(±2.49)
3.73
(±2.93)
3.12
(± 2.35)
0.49
Psychological disability4.16
(±2.62)
4.27
(±3.32)
4.12
(± 2.39)
0.87
Social disability1.88
(±2.36)
2.18
(±2.86)
1.78
(± 2.21)
0.63
Incapacity 3.19
(±2.48)
4.45
(±2.62)
2.75
(±3.31)
0.048
Total OHIP-1428.46
(±12.36)
31.36
(±14.37)
27.47
(±11.67)
0.3735
± = standard deviation; p = statistical significance at 0.05; * = Student’s t-test.
Table 2. Good and poor quality of life related to oral health regarding gender.
Table 2. Good and poor quality of life related to oral health regarding gender.
QUALITY of LIFEFEMALEMALETOTALOR
(CI)
p *
N (%)N (%)N (%)
FUNCTIONAL LIMITATIONS
GOOD7 (65.6)20 (62.5)27 (62.8)1.05
(0.21–5.95)
0.94
POOR4 (36.4)12 (37.5)16 (37.2)
TOTAL11 (100)32 (100)43 (100)
PAIN
GOOD5 (45.5)17 (53.1)22 (51.2)0.73
(0.15–3.60)
0.66
POOR6 (54.5)15 (46.9)21 (48.8)
TOTAL11 (100)32 (100)43 100
PSYCHOLOGICAL DISCOMFORT
GOOD5 (45.5)17 (53.1)22 (51.2)0.73
(0.15–3.60)
0.66
POOR6 (54.5)15 (46.9)21 (48.8)
TOTAL11 (100)32 (100)43 (100)
PHYSICAL DISABILITY
GOOD7 (65.6)22 (68.7)29 (67.4)0.79
(0.16–4.61)
0.75
POOR4 (36.4)10 (31.3)14 (32.6)
TOTAL11 (100)32 (100)43 (100)
PSYCHOLOGICAL DISABILITY
GOOD6 (54.5)18 (56.3)24 (55.8)1.16
(0.22–6.75)
0.83
POOR5 (45.5)14 (43.7)19 (44.2)
TOTAL11 (100)32 (100)43 (100)
SOCIAL DISABILITY
GOOD6 (54.5)16 (50)22 (51.2)1.2
(0.25–6.1)
0.79
POOR5 (45.5)16 (50)21 (48.8)
TOTAL11 (100)32 (100)43 (100)
HANDICAP
GOOD4 (36.4)18 (56.3)22 (51.2)0.44
(0.08–2.21)
0.25
POOR7 (65.6)14 (43.7)21 (48.8)
TOTAL11 (100)32 (100)43 (100)
TOTAL
GOOD5 (45.5)17 (53.1)22 (51.2)0.73
(0.15–3.60)
0.66
POOR6 (54.5)15 (46.9)21 (48.8)
TOTAL11 (100)32 (100)43 (100)
% = percentage; OR = odds ratio; CI: confidence interval 95%; * = chi2 test; p = statistical significance at 0.05.
Table 3. The relation of the presence of oral lesions to AIDS with good or poor quality of life.
Table 3. The relation of the presence of oral lesions to AIDS with good or poor quality of life.
ORAL AND DENTAL LESIONS TOTAL
N = 143
OHRQoLp
GOOD
N = 80
POOR
N = 73
DENTALS
(N = 68)
CARIES3618
(50%)
18
(50%)
>0.05
TOOTH LOSS432221>0.05
RESIDUAL DENTAL ROOTS 2111
(52.3%)
10
(47.6%)
>0.05
GINGIVITIS95
(55.5%)
4
(44.4%)
PERIAPICAL
ABSCESS
202
(100%)
TOTAL 6834
(50%)
34
(50%)
>0.05
AIDS-RELATED ORAL LESIONS
(N = 19)
HAIRY LEUKOPLAKIA41
(25%)
3
(75%)
ANGULAR CHEILITIS 82
(25%)
6
(75%)
CANDIDIASIS 72
(28.5%)
5
(71.4%)
TOTAL195
(26.3%)
14
(73.6%)
0.03;
OR 3.1
(CI 1.04–9.61)
ORAL LESIONS NOT RELATED TO HIV/AIDS
(N = 13)
FISSURED TONGUE 22
(100%)
0
SABURRAL TONGUE 22
(100%)
0
MELANOTIC MACULA 32
(66.6%)
1
(33.3%)
XEROSTOMIA63
(50%)
3
(50%)
TOTAL139
(69.2%)
4
(30.7%)
>0.05
OHRQoL = oral health-related quality of life; p = chi-square; OR = odds ratio; CI = confidence interval; candidiasis = pseudomembranous and erythematous.
Table 4. Oral health-related quality of life in different countries determined using OHIP 14/49 as a research tool.
Table 4. Oral health-related quality of life in different countries determined using OHIP 14/49 as a research tool.
AUTHOR/
YEAR
COUNTPOPULATION Oral Health Index Profile—49 Dimensions
NTOT1234567
Yengopal and Naidoo (2008) [10]SO AFR N/S
WITH AROL
7182.1215.5218.1515.5312.5410.384.185.99
Yengopal and Naidoo (2008) [10]SO AFRN/S
WITHOUT AROL
7914.44.946.151.351.160.500.110.19
Sánchez et al. (2011) [25]ARGAMBULATORY20083141714111178
Tomar et al. (2011) [27]USAAMBULATORY 59453.711.61011.87.35.63.93.5
Vasconcelos Moreira et al. (2021) [11]POR AMBULATORY 664123.324.223.214.221.415.211.11.4
Oral Health Index Profile—14 Dimensions
AUTHOR/
YEAR
COUNTPOPULATIONNTOT1234567
Mulligan et al. (2008) [15] USAAMBULATORY59728.4
Santo et al. (2010) [26]POR AMBULATORY1015.83
Busato et al. (2013) [16]BRAAMBULATORY 1956.3
de Quadros Coelho et al. (2015) [14]BRAAMBULATORY42212.29
Mohamed et al. (2017) [18]MAL AMBULATORY1218.81.71.32.11.50.90.50.8
Umeizudike et al. (2021) [30]NIGAMBULATORY 3528.05
Umniyati et al. (2022) [31]INDOINMATE JAIL 2411
Umniyati et al. (2022) [31]INDO INMATE JAIL 3017.5
PRESENT STUDYMEXINSTITUTIONAL 4328.465.234.586.143.284.161.883.19
Count = country; SO AFR = South Africa; ARG = Argentina; USA = United States of America; POR = Portugal; BRA = Brazil; MAL = Malaysia; NIG = Nigeria; INDO = Indonesia; MEX = Mexico; TOT = total value of OHIP; 1 = functional limitation; 2 = physical pain; 3 = psychological discomfort; 4 = physical disability; 5 = psychological disability; 6 = social disability; 7 = handicap.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gaitán-Cepeda, L.A.; Castillo-Martínez, N.A.; Villanueva-Vilchis, M.d.C.; Chávez-Méndez, J.R.; Peralta-Alegría, Á.G.; Ferré-Soto, J.P.; Rivera-Reza, D.I. Oral Health-Related Quality of Life in an Institutionalized Population with HIV+/AIDS in the Northern Region of Mexico. Healthcare 2024, 12, 1352. https://doi.org/10.3390/healthcare12131352

AMA Style

Gaitán-Cepeda LA, Castillo-Martínez NA, Villanueva-Vilchis MdC, Chávez-Méndez JR, Peralta-Alegría ÁG, Ferré-Soto JP, Rivera-Reza DI. Oral Health-Related Quality of Life in an Institutionalized Population with HIV+/AIDS in the Northern Region of Mexico. Healthcare. 2024; 12(13):1352. https://doi.org/10.3390/healthcare12131352

Chicago/Turabian Style

Gaitán-Cepeda, Luis Alberto, Nydia Alejandra Castillo-Martínez, María del Carmen Villanueva-Vilchis, José Román Chávez-Méndez, Ángel Gastón Peralta-Alegría, Jaime Paúl Ferré-Soto, and Diana Ivette Rivera-Reza. 2024. "Oral Health-Related Quality of Life in an Institutionalized Population with HIV+/AIDS in the Northern Region of Mexico" Healthcare 12, no. 13: 1352. https://doi.org/10.3390/healthcare12131352

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop